کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3368766 1592354 2015 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Monitoring the patient response as an alternative to commercial negative quality control in infectious serology
ترجمه فارسی عنوان
نظارت بر پاسخ بیمار به عنوان یک جایگزین برای کنترل کیفیت منفی تجاری در سرولوژیک عفونی
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی میکروبیولوژی و بیوتکنولوژی کاربردی
چکیده انگلیسی


• Commercial quality control for qualitative infectious serology has disadvantages.
• An alternative, monitoring the median patient seronegative response, was evaluated.
• Compared with the commercial method, the alternative has important advantages.

BackgroundTraditional internal quality control schemes for qualitative infectious serology mostly rely on the use of commercial positive and negative quality control materials. However, with respect to the negative control, target values provided by the manufacturer are often poorly defined and non-commutability of the commercial materials further complicates correct interpretation of control results.An alternative quality control procedure using the median patient seronegative response is presented.Study designDaily patient median responses were calculated for our Hepatitis B surface antigen, Hepatitis B core antibody, Hepatitis C antibody and HIV antigen/antibody test systems. Because of the low prevalence of these viruses in our area, most patient responses are negative. A minimum of 5 patient samples per day was required to generate a stable daily median. Control limits were calculated and daily patient medians were plotted against commercial quality control results.ResultsCommercial negative controls and daily patient medians mostly behaved in the same way. Nevertheless, for the Hepatitis B surface antigen test, patient medians frequently exceeded the calculated control limit in contrast to commercial quality controls. This confirms that target ranges provided by the manufacturer are not always adequate. Moreover, an important matrix-related interference occurred on our HIV antigen/antibody test system and correct interpretation was only possible using daily patient median results.ConclusionMonitoring the daily patient median response can be a valuable alternative to traditional commercial negative quality control. It's easy to perform, cost-free, provides additional information with respect to matrix effects and allows for the establishment of well-defined control limits.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Clinical Virology - Volume 72, November 2015, Pages 30–35
نویسندگان
, , , ,